Login / Signup

Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth.

Kevin M BlumJacob C ZbindenAbhay B RamachandraStephanie E LindseyJason M SzafronJames W ReinhardtMegan HeitkemperCameron A BestGabriel J M MirhaidariYu-Chun ChangAnudari UlziibayarJohn M KellyKejal V ShahJoseph D DrewsJason ZakkoShinka MiyamotoYuichi MatsuzakiRyuma IwakiHira AhmadRobert Scott DaultonDrew MusgraveMatthew G WietEric HeuerEmily LawsonErica SchwarzMichael R McDermottRajesh KrishnamurthyRamkumar KrishnamurthyKan HorAimee K ArmstrongBrian A BoeDarren P BermanAaron J TraskJay D HumphreyAlison L MarsdenToshiharu ShinokaChristopher K Breuer
Published in: Communications medicine (2022)
These findings provide insights into TEVG remodeling, and have important implications for clinical use and future development of TEVGs for children with congenital heart disease.
Keyphrases
  • young adults
  • bone marrow
  • current status
  • cell therapy
  • platelet rich plasma
  • stem cells
  • mesenchymal stem cells